Technical Assistant Immuno Assay Development (m/f)
Protagen AG develops innovative diagnostic solutions for the improvement of diagnosis, drug development and therapy in autoimmune diseases. We believe that our employees are our most important asset and are dedicated to provide encouraging working conditions, challenging tasks as well as individual employee development programs.
Perform assay development-, optimization-, and validation-experiments on an ELISA or Luminex® - platform
Plan, perform, analyze, report and trouble-shoot experiments
Manufacture components and kits, assist in creating new production documents
Generate reports as well as write and revise SOPs according to ISO requirements
Experience and Qualifications:
Technical Assistant (BTA, CTA, MTA), Biology Laboratory Assistant, or B.Sc. in Molecular Biology or Biotechnology
Minimum 2 years of work experience in reagent or assay development in an industrial setting is preferred
Thorough knowledge and understanding of standard immunological techniques, including Enzyme Linked Immuno Sorbent Assay (ELISA), and a multiplex platform
Experience with human biological samples is required
Familiarity with ISO (9001,13485) requirements is preferred
Effective organizational skills as well as high degree of accuracy and attention to detail
Fluent in German; good workplace communication and writing skills in English
Experience with Microsoft Office (especially Excel and Word)
We are pleased to receive your complete application documents in German or English language via email as well as your earliest starting date and salary expectations. Please provide all relevant documents in one or two PDF documents.
Protagen AG Dr. Petra Weingarten, Director Human Resources Otto-Hahn-Straße 15, 44227 Dortmund Phone: +49 231/9742-6300 email@example.com
Bitte beziehen Sie sich bei Ihrer Bewerbung auf jobvector
Über Protagen AG
Protagen AG is a leading specialist in the development of novel diagnostic tests in autoimmune diseases. The company focuses its assay development programs on disease specific autoantibodies. Protagen expects to become the dominating provider for novel products in autoimmune-Dx and CDx.